SOPHiA GENETICS (SOPH) Receivables (2020 - 2025)

SOPHiA GENETICS's Receivables history runs 6 years deep, the most recent figure standing at $15.0 million for Q4 2025.

• In Q4 2025, Receivables rose 101.73% year-over-year to $15.0 million; the TTM figure through Dec 2025 stood at $15.0 million (up 101.73% YoY), while the FY2025 annual figure was $15.0 million, up 101.73% from the prior year.
• Receivables came in at $15.0 million for Q4 2025 at SOPHiA GENETICS, up from $8.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $15.0 million in Q4 2025 to a low of $6.1 million in Q4 2022.
• A 5-year average of $9.1 million and a median of $9.5 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 123.71% in 2023 and sank 45.15% in 2024, its largest moves.
• SOPHiA GENETICS's Receivables stood at $6.3 million in 2021, then decreased by 3.47% to $6.1 million in 2022, then jumped by 123.71% to $13.6 million in 2023, then tumbled by 45.15% to $7.4 million in 2024, then jumped by 101.73% to $15.0 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $15.0 million, $8.5 million, and $9.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison